Bioaggregate Inhibits Osteoclast Differentiation, Fusion, and Bone Resorption In Vitro.

[1]  B. Peng,et al.  Effect of BioAggregate on osteoclast differentiation and inflammatory bone resorption in vivo. , 2015, International endodontic journal.

[2]  C. Keskin,et al.  Color stabilities of calcium silicate-based materials in contact with different irrigation solutions. , 2015, Journal of endodontics.

[3]  M. Glogauer,et al.  Adseverin plays a role in osteoclast differentiation and periodontal disease‐mediated bone loss , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  J. Koh,et al.  Effect of Biodentine and Bioaggregate on odontoblastic differentiation via mitogen-activated protein kinase pathway in human dental pulp cells. , 2015, International endodontic journal.

[5]  M. Glogauer,et al.  The Actin Binding Protein Adseverin Regulates Osteoclastogenesis , 2014, PloS one.

[6]  A. Qin,et al.  The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling. , 2014, Biomaterials.

[7]  K. Safavi,et al.  Trace metal contents of three tricalcium silicate materials: MTA Angelus, Micro Mega MTA and Bioaggregate. , 2014, International endodontic journal.

[8]  C. Kao,et al.  Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages. , 2013, Journal of endodontics.

[9]  B. Diehl-seifert,et al.  Silicate modulates the cross‐talk between osteoblasts (SaOS‐2) and osteoclasts (RAW 264.7 cells): Inhibition of osteoclast growth and differentiation , 2012, Journal of cellular biochemistry.

[10]  G. Gavini,et al.  Evaluation of radiopacity, pH, release of calcium ions, and flow of a bioceramic root canal sealer. , 2012, Journal of endodontics.

[11]  T. Miyamoto.  Regulators of osteoclast differentiation and cell-cell fusion. , 2011, The Keio journal of medicine.

[12]  E. Jimi,et al.  Mineral Trioxide Aggregate Inhibits Osteoclastic Bone Resorption , 2011, Journal of dental research.

[13]  G. Mundy,et al.  Advances in osteoclast biology: old findings and new insights from mouse models , 2011, Nature Reviews Rheumatology.

[14]  Aldo R Boccaccini,et al.  A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. , 2011, Biomaterials.

[15]  E. Jimi,et al.  Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. , 2011, Journal of biomedical materials research. Part A.

[16]  B. Peng,et al.  Effect of bioaggregate on differentiation of human periodontal ligament fibroblasts. , 2010, International endodontic journal.

[17]  E. Brown,et al.  Strontium Ranelate Decreases Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastic Differentiation In Vitro: Involvement of the Calcium-Sensing Receptor , 2010, Molecular Pharmacology.

[18]  U. Kolb,et al.  The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells. , 2010, Biomaterials.

[19]  B. Peng,et al.  Effect of bioaggregate on mineral-associated gene expression in osteoblast cells. , 2010, Journal of endodontics.

[20]  M. Glogauer,et al.  Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Gordon,et al.  Molecular mediators of macrophage fusion. , 2009, Trends in cell biology.

[22]  M. Ishii,et al.  Osteoclast cell fusion: mechanisms and molecules , 2008, Modern rheumatology.

[23]  Elizabeth H. Chen,et al.  Cell–cell fusion , 2007, FEBS letters.

[24]  Hiroshi Takayanagi,et al.  The molecular understanding of osteoclast differentiation. , 2007, Bone.

[25]  Y. Toyama,et al.  DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells , 2005, The Journal of experimental medicine.

[26]  Y. Nogi,et al.  Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1* , 2004, Journal of Biological Chemistry.

[27]  K. Toh,et al.  RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis , 2004, The Journal of experimental medicine.

[28]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[29]  Hiroshi Takayanagi,et al.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.

[30]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[31]  Seok-Woo Chang,et al.  Effects of ProRoot MTA, Bioaggregate, and Micromega MTA on odontoblastic differentiation in human dental pulp cells. , 2014, Journal of endodontics.

[32]  E. Björn,et al.  Soluble silica inhibits osteoclast formation and bone resorption in vitro. , 2014, Acta biomaterialia.

[33]  Jong-Hyun Kim,et al.  X-Ray diffraction analysis of white ProRoot MTA and Diadent BioAggregate. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[34]  N. Udagawa,et al.  Action of RANKL and OPG for osteoclastogenesis. , 2009, Critical reviews in eukaryotic gene expression.

[35]  Seoung-Hoon Lee,et al.  NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). , 2008, Molecular endocrinology.